The acquisition of mutant BRAF is an important initiating event for melanoma development, although the process by which transformed melanocytes escape from keratinocyte control and disseminate to other organs is not well understood. Boyd et al. (2012) provide evidence that oncogenic BRAF contributes to the microenvironmental escape of melanocytes through the downregulation of E-cadherin expression via the transcriptional suppressor Tbx3
Melanoma is a highly metastatic and lethal form of skin cancer. The protein kinase BRAF is mutated i...
SummaryActivating mutations in BRAF are the most common genetic alterations in melanoma. Inhibition ...
Melanoma is the deadliest type of skin cancer with an increasing incidence for past two decades. Onc...
The acquisition of mutant BRAF is an important initiating event for melanoma development, although t...
Mutational activation of BRAF is the earliest and most common genetic alteration in human melanoma. ...
The main function of the mammalian skin is to protect the organism against various deleterious envir...
BRAFV600E is the most common mutation driver in melanoma. This mutation is known to cause a brief bu...
The BRAF oncogene demonstrates a characteristic mutation (V600E) in a significant fraction of cutane...
Approximately 50% of melanomas require oncogenic B-RAF V600E signaling for proliferation, survival, ...
Abstract Background The initial use of BRAF targeted therapeutics in clinical trials has demonstrate...
The V600E mutation of BRAF (BRAF), which constitutively activates the ERK/MAPK signaling pathway, is...
Since the discovery of BRAF mutations in over 50% of melanomas, various small molecule inhibitors ag...
Cutaneous melanoma, the most aggressive form of skin cancer, remains one of the most difficult to tr...
Approximately 50% of melanomas require oncogenic B-RAF(V600E) signaling for proliferation, survival,...
SummaryMelanoma patients with oncogenic BRAFV600E mutation have poor prognoses. While the role of BR...
Melanoma is a highly metastatic and lethal form of skin cancer. The protein kinase BRAF is mutated i...
SummaryActivating mutations in BRAF are the most common genetic alterations in melanoma. Inhibition ...
Melanoma is the deadliest type of skin cancer with an increasing incidence for past two decades. Onc...
The acquisition of mutant BRAF is an important initiating event for melanoma development, although t...
Mutational activation of BRAF is the earliest and most common genetic alteration in human melanoma. ...
The main function of the mammalian skin is to protect the organism against various deleterious envir...
BRAFV600E is the most common mutation driver in melanoma. This mutation is known to cause a brief bu...
The BRAF oncogene demonstrates a characteristic mutation (V600E) in a significant fraction of cutane...
Approximately 50% of melanomas require oncogenic B-RAF V600E signaling for proliferation, survival, ...
Abstract Background The initial use of BRAF targeted therapeutics in clinical trials has demonstrate...
The V600E mutation of BRAF (BRAF), which constitutively activates the ERK/MAPK signaling pathway, is...
Since the discovery of BRAF mutations in over 50% of melanomas, various small molecule inhibitors ag...
Cutaneous melanoma, the most aggressive form of skin cancer, remains one of the most difficult to tr...
Approximately 50% of melanomas require oncogenic B-RAF(V600E) signaling for proliferation, survival,...
SummaryMelanoma patients with oncogenic BRAFV600E mutation have poor prognoses. While the role of BR...
Melanoma is a highly metastatic and lethal form of skin cancer. The protein kinase BRAF is mutated i...
SummaryActivating mutations in BRAF are the most common genetic alterations in melanoma. Inhibition ...
Melanoma is the deadliest type of skin cancer with an increasing incidence for past two decades. Onc...